Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-01-27
DOI
https://doi.org/10.1016/j.eclinm.2024.103065
Citations
1
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

Susan M. van den Berg, Birgit E. P. J. Vriens, Rhodé M. Bijlsma, Monique E.M.M. Bos et al.
1 citations
EClinicalMedicine
Cancer Treatment and Pharmacology
1.05
article

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

Susan M. van den Berg, Birgit E. P. J. Vriens, Rhodé M. Bijlsma, Monique E.M.M. Bos, Esther Oomen‐de Hoop, Niels A.D. Guchelaar, Peter Nieboer, Joan B. Heijns, Mandy M van Rosmalen, Karin Beelen, Lonneke W. Kessels, Ron H.J. Mathijssen, Marlies L. van Bekkum, Lisanne C. Hamming, Maaike de Boer
article en
1 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 80
Radboud University Nijmegen (NL), Breast Cancer Research Foundation (US), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Centrum Leeuwarden (NL), University Medical Center Utrecht (NL), Reinier de Graaf Hospital (NL), Amphia Ziekenhuis (NL), Cancer Genomics Centre (NL), Erasmus MC Cancer Institute (NL), Rijnstate Hospital (NL), Deventer Ziekenhuis (NL), Maastro Clinic (NL)
Good health and well-being
Openalex Percentile: Top 26%
Cancer Treatment and Pharmacology
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial — Susan M. van den Berg, Birgit E. P. J. Vriens, et al. · EClinicalMedicine (2025) | TGRS Research Map | TGRS